A Billion-Dollar Billing Crisis

Healthcare providers in the United States lose an estimated $262 billion each year to claim denials — situations where insurance companies reject reimbursement for services already delivered. The process of appealing those denials is almost entirely manual: staff must review denial codes, gather clinical documentation, write appeal letters, and resubmit claims, often spending hours on a single case with no guarantee of success. For hospitals and physician groups operating on thin margins, the drag from denied claims can be existential.

What They're Building

Amperos Health is building an AI-native platform that automates the full denial management and revenue cycle workflow for healthcare providers. Rather than layering automation on top of legacy processes, the company rethinks the workflow from the ground up — using large language models trained on clinical and billing data to identify denial patterns, draft appeals, and route cases through the right corrective actions automatically. The platform integrates directly with existing electronic health record systems and practice management software, making it deployable without expensive implementation projects.

The company raised a $4.2M seed round in June 2025, led by Uncork Capital and Neo, with additional backing from Nebular and a strong cohort of angel investors with backgrounds at OpenAI, Twilio, and Stripe. That mix of healthcare and technology investor conviction reflects Amperos Health’s positioning at the intersection of two industries: the complexity of healthcare billing and the transformative potential of modern AI.

The Revenue Cycle Opportunity

Revenue cycle management is one of healthcare’s most persistent operational burdens, accounting for roughly 25 cents of every dollar spent on administration. Denial rates have climbed steadily as payer policies grow more complex, and the shortage of skilled billing staff makes the manual appeals model increasingly unsustainable. Amperos Health’s approach targets this gap directly: by automating the denial response workflow, providers can recover revenue faster, reduce write-offs, and free clinical staff to focus on patient care rather than paperwork. The company is positioned in a large and underserved market where even incremental automation delivers measurable financial impact.